Clenbuterol & Yohimbine Mix — ZPHC (40 mL Multidose Vial, 5440 mcg/mL)

Clenbuterol & Yohimbine Mix — liquid β₂-agonist + α₂-antagonist research blend
40 mL multidose vial • 5440 µg per mL (217.6 mg total actives)

• Synergistic adrenergic activation: β₂ stimulation from Clenbuterol + α₂ blockade from Yohimbine → amplified thermogenesis and fatty acid mobilization.
• High-volume research format: 40 mL multidose vial enables long-duration titration studies and precise aliquot sampling.
• Stabilized solution: nitrogen overlay, sterile liquid matrix, sealed under Profi-Line QC conditions.
• Protocol example: escalating-dose adrenergic models; alternating β₂/α₂ pathways for receptor-responsiveness analysis.
• Profi-Line quality: Certified Reference Material (CRM), ≥99% purity by HPLC, full sterility & endotoxin panel, validated via scratch-code.
• Tamper-evident flip-cap • clear volumetric markings • “Do Not Refrigerate / Protect From Light” handling grade.